High-performance mode-locked erbium-doped fiber laser using a NbN quantum dot saturable absorber
Journal of Optics · 01.03.2026 · 28 (3) · 035504
DOI: 10.1088/2040-8986/ae4bef ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Optics, online erschienen am 10.03.2026. Verfasst von Jian-Zhong Yin und 4 weiteren Autor:innen. Die Arbeit nennt 42 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
This study explores the application of niobium nitride (NbN) quantum dots (QDs)—a topological semimetal material—as a saturable absorber (SA) for mode-locked erbium-doped fiber lasers. NbN-QDs were synthesized via liquid-phase exfoliation followed by high-speed centrifugation and integrated into a fiber laser cavity for the first time. The resulting laser operated at a central wavelength of 1574.79 nm and generated mode-locked pulses with a duration of 818 fs and a signal-to-noise ratio of 65.86 dB. Nonlinear optical measurements revealed a modulation depth of 6.12% and a saturation intensity of 172.6 MW cm −2 . These findings underscore the strong potential of NbN QDs as high-performance SAs in ultrafast photonic devices.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Yin, J., Huang, Y., Xin, Z., Tao, L., & Long, H. (2026). High-performance mode-locked erbium-doped fiber laser using a NbN quantum dot saturable absorber. Journal of Optics, 28(3), 035504. https://doi.org/10.1088/2040-8986/ae4bef
Vancouver
Yin J, Huang Y, Xin Z, Tao L, Long H. High-performance mode-locked erbium-doped fiber laser using a NbN quantum dot saturable absorber. Journal of Optics. 2026;28(3):035504. doi:10.1088/2040-8986/ae4bef
BibTeX
@article{Yin2026,
author = {Yin, Jian-Zhong and Huang, Ying-Yi and Xin, Zhang and Tao, Li-Li and Long, Hui},
title = {High-performance mode-locked erbium-doped fiber laser using a NbN quantum dot saturable absorber},
journal = {Journal of Optics},
year = {2026},
volume = {28},
number = {3},
pages = {035504},
doi = {10.1088/2040-8986/ae4bef}
}
EUVIMED